Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1984-6-7
|
pubmed:abstractText |
Single-dose pharmacokinetics of mezlocillin were studied in 53 newborn infants (72% less than or equal to 36 weeks' gestation) given ampicillin and an aminoglycoside for suspected or proved sepsis. Mezlocillin (75 mg/kg IV or IM) was substituted for ampicillin, serum was assayed microbiologically, and noncompartmental pharmacokinetic parameters were calculated. Analysis of covariance showed that dose/area under the serum concentration-time curve for mezlocillin was influenced by body weight, intramuscular administration, and treatment with gentamicin. A dual intravenous/intramuscular nonlinear regression model yielded an apparent intramuscular bioavailability of 84%. Clearance was proportional to body weight (WT) (r2 = 0.70). Mean CL/WT (0.078 L/hr/kg) was one-half adult values and influenced by gestational age. Steady-state volume of distribution varied linearly with weight (r2 = 0.80), the mean value (0.38 L/kg) being twice that in adults. Mezlocillin half-life (mean 3.71 hours) exceeded adult values and did not correlate with weight. Twenty-four newborn infants received 75 mg/kg mezlocillin every 6 or every 8 hours, along with gentamicin, during the first 7 to 10 days of life. Peak (1.5 hours) and trough (6 or 8 hours) concentrations were determined; the latter decreased from day 3 to days 7 to 10, suggesting a possible postnatal age-dependent change in mezlocillin elimination. Although mezlocillin disposition is affected by age and therapeutic factors, weight alone may adequately predict dosing requirements.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-3476
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
773-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6716226-Adult,
pubmed-meshheading:6716226-Bacterial Infections,
pubmed-meshheading:6716226-Female,
pubmed-meshheading:6716226-Gestational Age,
pubmed-meshheading:6716226-Half-Life,
pubmed-meshheading:6716226-Humans,
pubmed-meshheading:6716226-Infant, Newborn,
pubmed-meshheading:6716226-Infant, Premature, Diseases,
pubmed-meshheading:6716226-Infusions, Parenteral,
pubmed-meshheading:6716226-Kinetics,
pubmed-meshheading:6716226-Male,
pubmed-meshheading:6716226-Metabolic Clearance Rate,
pubmed-meshheading:6716226-Mezlocillin,
pubmed-meshheading:6716226-Time Factors,
pubmed-meshheading:6716226-Tissue Distribution
|
pubmed:year |
1984
|
pubmed:articleTitle |
Developmental pharmacokinetics of mezlocillin in newborn infants.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|